Novan spinoff KNOW Bio raises $4.6M from 49 investors
Biotechnology company KNOW Bio, a spinoff from Novan, has raised another $4.6 million in an equity offering, according to a filing with the Securities and Exchange Commission.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed